We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA REOPENS COMMENT PERIOD ON QT/QTc ICH GUIDANCES
FDA REOPENS COMMENT PERIOD ON QT/QTc ICH GUIDANCES
January 6, 2005
Prompted by a request from Wyeth, the FDA has reopened the public comment period for two International Conference on Harmonisation (ICH) draft guidances that assess possible cardiac risks associated with new drugs.